Harald Carlsen
Corporate Officer/Principal bij University of Oslo
Profiel
Harald Carlsen is the founder of Cgene AS, which was founded in 1985.
He held the title of Managing Director from 2010 to 2013.
Currently, he is a Senior Scientist at the University of Oslo.
Actieve functies van Harald Carlsen
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Oslo | Corporate Officer/Principal | 23-04-2010 |
Eerdere bekende functies van Harald Carlsen
| Bedrijven | Functie | Einde |
|---|---|---|
Cgene AS
 Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Cgene AS
Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Commercial Services |
